1. A translational bioinformatic approach in identifying and validating an interaction between Vitamin A and CYP19A1. (December 2015) Authors: Philips, Santosh; Zhou, Jing; Li, Zhigao; Skaar, Todd; Li, Lang Journal: BMC genomics Issue: Volume 16:Number 7(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AMPD1 polymorphism and response to regadenoson. (November 2015) Authors: Saab, Rayan; Zouk, Aline N; Mastouri, Ronald; Skaar, Todd C; Philips, Santosh; Kreutz, Rolf P Journal: Pharmacogenomics Issue: Volume 16:Number 16(2015) Page Start: 1807 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers. (24th February 2022) Authors: Shugg, Tyler; Ly, Reynold C.; Rowe, Elizabeth J.; Philips, Santosh; Hyder, Mustafa A.; Radovich, Milan; Rosenman, Marc B.; Pratt, Victoria M.; Callaghan, John T.; Desta, Zeruesenay; Schneider, Bryan P.; Skaar, Todd C. Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Common genetic polymorphisms of adenosine A2A receptor do not influence response to regadenoson. (April 2017) Authors: Berlacher, Mark; Mastouri, Ronald; Philips, Santosh; Skaar, Todd C; Kreutz, Rolf P Journal: Pharmacogenomics Issue: Volume 18:Number 6(2017) Page Start: 523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗